Investment Firm
Overview
Immunovia is a diagnostics company that focuses on the early detection of pancreatic cancer through blood-based testing.
Aug 05, 2024
Grant
Highlights
N/A
Location
Social
N/A
Participant Investors
1
Investor Name |
---|
National Institutes of Health |
Immunovia raised $4500000 on 2024-08-05 in Grant
Immunovia is a diagnostics company that focuses on the early detection of pancreatic cancer through blood-based testing.
Company Funding History
5
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jun 01, 2015 | Grant - Immunovia | 1 | - | 4.6M |
Jun 04, 2020 | Post-IPO Equity - Immunovia | - | 43.5M | |
May 20, 2024 | Post-IPO Debt - Immunovia | - | 1.4M | |
Aug 05, 2024 | Grant - Immunovia | 1 | - | 4.5M |
Recent Activity
There is no recent news or activity for this profile.